Home / Stock ratings / Crypto-Linked Stocks / CORZ
Stock rating
Core Scientific, Inc. (CORZ) Stock Rating & Analysis
As of September 24, 2026, MELANY rates Core Scientific, Inc. 55 out of 100 (Very Promising). Its highest factor score is analyst sentiment at 92, and its lowest is risk-adjusted profile at 25.
MELANY ratingRated 2026-09-24CORZ · composite score
Why CORZ scores 55/100
CORZ's 8 factor scores run from 25 to 92, and 2 of them sit above its composite of 55. Here is how CORZ breaks down.
Whether the price looks cheap or expensive against earnings, growth, and peers.
- FCF yield 8.0%
Margins, returns on capital, and balance-sheet strength.
Direction and relative strength of the recent share-price trend.
History of beating or missing estimates, and where estimates are heading.
What Wall Street price targets and revisions are signalling.
- Analyst targets 90% upside
Near-term events that could move the stock.
Upside weighed against volatility and drawdown risk.
How the current rate and market regime suits this kind of company.
How CORZ compares
As of October 15, 2026, Core Scientific, Inc. ranks 5th of 15 in Crypto-Linked Stocks, where the average score is 52.
Key risks for CORZ
- Short interest 23% of float, high volatility risk on news
- High beta 5.5, amplifies market drawdowns 1.8x+ in selloffs
- Performance partly driven by Technology sector, rotation away from this theme would hurt
- No positive trailing earnings, valuation cannot be anchored to current P/E
Sector and theme context
Core Scientific, Inc. sits in the Technology sector theme, which MELANY currently rates 95/100 for strength. Theme strength feeds CORZ's momentum and catalyst factors above.
CORZ trade plan (Pro)
MELANY has a full position plan for Core Scientific, Inc.: a smart entry zone, an alert level, position sizing, and quarterly review triggers. It is part of Market Eyes Pro, and the first 30 days are free.
How MELANY rates CORZ
MELANY is a rules-based engine that scores every stock from 0 to 100 across eight weighted factors, then re-scores as new price, earnings, and fundamental data arrive. Core Scientific, Inc.'s 55/100 reflects speculative factor weighting for its profile. Position framework managed by score-based check-ins, not a fixed holding period.
Ratings are algorithmic and change with the data. They are research and education, not personalized investment advice.
Frequently asked questions about CORZ
Is Core Scientific, Inc. (CORZ) a buy?
As of 2026-09-24, MELANY rated Core Scientific, Inc. Very Promising with a composite score of 55/100. That is a dated snapshot, not the live rating, and it is an algorithmic reading built from eight factors rather than personalized investment advice. Review the factor breakdown above and the disclaimer below before making any decision.
What is Core Scientific, Inc.'s MELANY score?
Core Scientific, Inc. (CORZ) has a MELANY composite score of 55/100, combining valuation, business quality, price momentum, earnings track record, analyst sentiment, catalyst setup, risk-adjusted profile, macro fit.
How is the CORZ stock rating calculated?
MELANY scores CORZ from 0 to 100 across eight weighted factors using live market and fundamental data, then refreshes the rating automatically as new data arrives.
Should I buy Core Scientific, Inc. stock?
That decision is yours; Market Eyes Live does not give buy or sell advice. What the data says: MELANY rates Core Scientific, Inc. (CORZ) Very Promising with a composite of 55/100 as of 2026-09-24. The factor breakdown above shows what is driving that, which is a better basis for a decision than any one-word verdict.
What is the CORZ stock price forecast?
MELANY does not publish price targets or forecasts for CORZ. Predicting a future price is exactly the kind of false precision the confidence framework avoids. Instead it scores today's setup, 55/100 across eight factors for Core Scientific, Inc., and re-scores automatically as new price, earnings, and fundamental data arrive.
Is CORZ stock overvalued or undervalued?
MELANY's valuation factor currently reads 71/100 for Core Scientific, Inc., where a higher score means the price looks more attractive on that measure. Scores in the 70s and above read as attractively priced, the mid range as roughly fair, and low scores as stretched. The factor breakdown above shows what drives CORZ's read.
What price should I buy CORZ at?
Rather than chasing the current price, MELANY computes a smart entry zone for CORZ: the price area where risk and reward actually favor a new position, plus an alert level and position sizing. The exact levels are part of Market Eyes Pro, which starts with a 30-day free trial.
What are the risks of buying CORZ stock?
The top risks MELANY currently flags for Core Scientific, Inc.: Short interest 23% of float, high volatility risk on news; High beta 5.5, amplifies market drawdowns 1.8x+ in selloffs; Performance partly driven by Technology sector, rotation away from this theme would hurt; No positive trailing earnings, valuation cannot be anchored to current P/E. The rating on this page already weighs these against the bullish factors; see the risk-adjusted profile score in the breakdown above.
Is Core Scientific, Inc. a good long-term investment?
For long-term durability the two factors that matter most are business quality, which MELANY scores 36/100 for Core Scientific, Inc., and earnings track record, at 31/100. The 55/100 composite blends those with six shorter-horizon factors. Durable quality at a fair price is the long-term case to test; this is research, not personalized investment advice.
Will CORZ stock go up?
Nobody can promise a stock's direction, and Market Eyes Live does not predict prices. The measurable part: MELANY's price momentum factor reads 43/100 for CORZ right now, and the catalyst setup factor tracks whether near-term events could move it. Both re-score automatically as the data changes.
How current is this CORZ rating?
The rating on this page is a snapshot of MELANY's read as of 2026-09-24. The price shown updates live, but the score is not recomputed on this page. MELANY re-scores CORZ continuously as new price, earnings, and fundamental data arrive, and the current rating is in the app (Pro, free for 30 days).
How this rating works
Market Eyes Live
Every rating graded in public, CORZ included
MELANY scores more than 11,000 U.S. stocks and ETFs, PRISM ranks conviction and APEX writes the plan with one entry zone. Free to start on iOS and the web.